Prof. Han is specialized in treating patients with genitourinary system cancers, including bladder, kidney, prostate,adrenal gland, ureter, urethra, testis, epididymis, spermatic cord, and penis and so on. He is good at various kinds of urological operations, especially retroperitoneal lymph node dissection and inguinal lymphadenectomy.

Prof. Han perform laparscopic and open procedures to treat these cancers, often in a multi-disciplinary team approach with the integration of expertise by medical oncology and/or radiation oncology. He also pursued technical innovations which have transformed the management of these cancers including open inguinal lymphadenectomy, laparoscopic retroperitoneal lymph node dissection, open/ laparoscopic radical nephrectomy and laparoscopic radical prostatectomy.

Annually, Prof. Han perform approximately 100 partial/radical nephrectomy procedures for kidney cancer, 20 prostatectomy procedures for prostate cancer, 20 cystectomy procedures for bladder cancer, 20 lymph node dissections for penile cancer, and 15 retroperitoneal lymph node dissections for testis cancer. He also has unique expertise in managing rare urologic cancers and salvage procedures for recurrent cancers of the bladder and prostate that have failed initial therapy with surgery or other treatments.

Prof. Han trained in the Tong Ji University School of Medicine. He acquired M.D in Tong Ji University School of Medicine  and completed his Residency training in Tong Ji hospital.

1．Kai Yao, Hyewon Youn, Xiaoyan Gao,Bijun Huang,Fangjian Zhou, Benyi Li and Hui Han*. Casein Kinase 2 Inhibition Attenuates Androgen Receptor Function and Cell Proliferation in PC Cells. The Prostate, 72 (4):1423-1430,  2012   (IF 4.14)

2．Kai Yao, Zai-Shang Li, Fang-Jian Zhou, Zi-Ke Qin, Zhuo-Wei Liu, Yong-Hong Li, Hui Han*. Anatomical retroperitoneoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors: initial operative experience, Asian Journal of Andrology ,16 (1):136-139,  2014   (IF 2.140)

3．Kai Yao, Peng Chen, Zi-jun Zou, Zi-Ke Qin, Zhuo-Wei Liu , Yong-Hong Li, Fang-Jian Zhou, Hui Han*. Disease specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density. Urologic Oncology: Seminars and Original Investigations, 2013, Dec 30. [Epub ahead of print] (IF 3.647)

4． Kai Yao, Zi-jun Zou, Zai-shang Li, Fang-Jian Zhou, Zi-Ke Qin, Zhuo-Wei Liu, Yong-Hong Li, Hui Han*. Fascia lata preservation during inguinal lymphadenectomy for penile cancer:rationale and outcome, Urology , 82 (8):642-647,  2013   (IF 2.424)

5．Kai Yao,  Hua Tu, Yong-Hong Li, Fang-Jian1 Zhou and Hui Han*. Modified Technique of Radical Inguinal Lymphadenectomy for Penile Carcinoma: Morbidity and Outcome, Journal of Urology, 184(8):546-552, 2011   (IF 3.696)

6．Han H*, Yao K, Zhou FJ. Modified Technique of radical inguinal lymphadenectomy to reduce the complication of skin necrosis for penile carcinoma, European Urology Supplements, 10(2): 339-340, 2011   (IF 2.162) 

7．Han H*, Youn YH, Yao K, Zhou FJ, Huang HB, Li BY. CK2-selective CK2 inhibitor: effect on AR receptor and cell cycle in castrationresistant prostate cancer cell line, European Urology Supplements, 10 (2): 292-293, 2011    (IF 2.162) 

8．Han H*, Yao K, Zhou FJ. Extroperitoneal lymph node dissection ( report of 7 cases). J of endourology .2008:22(supl 1):A286

Updated by International Office, Sun Yat-sen University Cancer Center